Challenged by limited treatment options for polymyalgia rheumatica? Be there for the next chapter of PMR treatment. Join us for a discussion on the role of this therapy, the clinical data that led to its approval, and linkages to another common rheumatic disease: RA. Developed and offered by Sanofi
Non-CME
